Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/27/2025

Renal Cell Carcinoma – Diagnostic and Staging Recommendations (ESMO)

Imaging‑Based Diagnosis

  • Over 50 % of renal cell carcinomas are discovered incidentally on imaging performed for unrelated reasons (ultrasound, CT, or MRI). Strong recommendation (European Society for Medical Oncology). [1][2]
  • Imaging is the primary diagnostic tool: abdominal ultrasound is the first‑line modality, followed by contrast‑enhanced CT for confirmation and accurate staging. Strong recommendation (ESMO). [1][3]4

Histopathologic Confirmation (Biopsy)

  • Core‑needle biopsy of a renal mass provides histopathologic confirmation with high sensitivity and specificity; it is especially advised before ablative therapies and in patients with metastatic disease prior to initiating systemic treatment. Strong recommendation (ESMO). [1][2]

Laboratory Tests for Prognostic Stratification (Not Diagnostic)

  • Serum creatinine, hemoglobin, complete blood count, LDH, C‑reactive protein, and corrected calcium are employed in prognostic scoring systems such as the IMDC risk model; they are not diagnostic biomarkers. Moderate recommendation (ESMO). [1][3]

Tissue Immunohistochemistry for Histologic Subtyping

  • Cytokeratin 7 (CK7) shows diffuse positivity in chromophobe renal carcinoma and is negative or only focally positive in oncocytoma, aiding differential diagnosis. Evidence level: moderate. [2][7]8
  • Immunohistochemistry and fluorescence in‑situ hybridisation (FISH) for TFE3/TFEB are recommended to detect MiT family translocations in young patients with suspected translocation‑associated renal tumors. Evidence level: moderate. [2][7]8

Paraneoplastic Syndromes Suggestive of RCC

  • Stauffer syndrome (laboratory hepatic abnormalities without hepatic metastases) can be a presenting feature of renal cell carcinoma. Evidence level: moderate. 1
  • Unexplained fever may accompany RCC and often resolves after tumor resection. Evidence level: moderate. 1

Common Pitfalls to Avoid

  • Do not interpret elevated LDH, calcium, or hemoglobin as diagnostic markers; they serve only prognostic purposes. Evidence level: moderate. 1
  • FDG‑PET is not recommended as a standard imaging modality for diagnosis or staging of clear‑cell renal carcinoma. Evidence level: moderate. 1